Tempus AI Financials
| TEM Stock | 69.77 0.23 0.33% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.14 | 2.64 |
|
|
The essential information of the day-to-day investment outlook for Tempus AI includes many different criteria found on its balance sheet. An individual investor should monitor Tempus AI's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Tempus AI.
Net Income |
|
Tempus | Select Account or Indicator | Build AI portfolio with Tempus Stock |
Tempus AI Stock Summary
Tempus AI competes with Doximity, Smith Nephew, Fresenius Medical, Cooper Companies, and Medpace Holdings. Tempus AI is entity of United States. It is traded as Stock on NASDAQ exchange.| Foreign Associate | Mexico |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US88023B1035 |
| Business Address | 600 West Chicago |
| Sector | Life Sciences Tools & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.tempus.com |
| Phone | 800 976 5448 |
Tempus AI Key Financial Ratios
| Return On Equity | -0.73 | ||||
| Profit Margin | (0.18) % | ||||
| Operating Margin | (0.18) % | ||||
| Price To Sales | 11.19 X | ||||
| Revenue | 693.4 M |
Tempus AI Key Balance Sheet Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Total Assets | 531.4M | 631.4M | 564.1M | 926.1M | 1.1B | 692.1M | |
| Other Current Liab | 64.2M | 71.8M | 106.9M | 114.4M | 131.6M | 77.2M | |
| Net Debt | (38.7M) | 130.1M | 322.4M | 127.1M | 146.2M | 153.5M | |
| Retained Earnings | (807.5M) | (1.1B) | (1.4B) | (2.2B) | (1.9B) | (1.8B) | |
| Accounts Payable | 33.8M | 46.0M | 54.4M | 53.8M | 61.9M | 46.7M | |
| Cash | 277.7M | 302.9M | 165.8M | 341.0M | 306.9M | 243.8M | |
| Net Receivables | 82.2M | 88.7M | 94.5M | 154.8M | 178.0M | 98.9M | |
| Good Will | 16.0M | 53.1M | 73.4M | 73.3M | 84.3M | 45.4M | |
| Inventory | 22.9M | 22.3M | 28.8M | 38.4M | 44.1M | 29.0M | |
| Other Current Assets | 21.2M | 24.7M | 29.5M | 26.1M | 30.1M | 22.3M | |
| Total Liab | 1.3B | 1.8B | 1.9B | 869.8M | 1.0B | 1.4B | |
| Total Current Assets | 404.0M | 438.6M | 350.3M | 667.6M | 767.7M | 510.9M | |
| Short Term Debt | 419K | 6.4M | 6.4M | 6.5M | 7.4M | 4.0M | |
| Intangible Assets | 37.3M | 37.3M | 21.9M | 11.7M | 10.5M | 10.0M | |
| Long Term Debt | 238.2M | 389.5M | 449.7M | 435.4M | 500.8M | 387.8M | |
| Net Invested Capital | (569.3M) | (739.5M) | (932.5M) | 491.8M | 565.5M | 593.8M | |
| Net Working Capital | 289.2M | 264.4M | 117.7M | 376.5M | 338.9M | 255.4M |
Tempus AI Key Income Statement Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Interest Expense | 15.2M | 21.9M | 46.9M | 53.7M | 61.7M | 64.8M | |
| Total Revenue | 257.9M | 320.7M | 531.8M | 693.4M | 797.4M | 837.3M | |
| Gross Profit | 83.6M | 130.2M | 286.2M | 381.1M | 438.3M | 460.2M | |
| Operating Income | (243.7M) | (265.4M) | (196.1M) | (691.1M) | (622.0M) | (590.9M) | |
| Ebit | (243.4M) | (267.3M) | (166.7M) | (647.7M) | (582.9M) | (553.8M) | |
| Research Development | 128.4M | 162.3M | 185.5M | 316.8M | 364.4M | 382.6M | |
| Ebitda | (219.5M) | (236.8M) | (133.3M) | (610.4M) | (549.4M) | (521.9M) | |
| Cost Of Revenue | 174.2M | 190.5M | 245.6M | 312.3M | 359.1M | 206.8M | |
| Income Before Tax | (259.2M) | (289.7M) | (213.8M) | (705.5M) | (635.0M) | (603.2M) | |
| Net Income | (259.2M) | (289.8M) | (214.1M) | (705.8M) | (635.2M) | (603.5M) | |
| Income Tax Expense | 604K | 66K | 288K | 266K | 239.4K | 227.4K | |
| Net Interest Income | (14.6M) | (18.9M) | (39.3M) | (42.6M) | (38.3M) | (40.2M) | |
| Interest Income | 623K | 3.0M | 7.6M | 11.1M | 12.7M | 13.4M |
Tempus AI Key Cash Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change To Inventory | 14.6M | (1.3M) | (6.6M) | (9.5M) | (11.0M) | (11.5M) | |
| Change In Cash | (235.8M) | 25.3M | (137.1M) | 175.2M | 157.7M | 165.6M | |
| Free Cash Flow | (223.8M) | (186.6M) | (248.9M) | (211.2M) | (190.0M) | (199.6M) | |
| Depreciation | 23.9M | 30.4M | 33.3M | 37.2M | 42.8M | 29.9M | |
| Other Non Cash Items | 8.2M | 19.4M | 4.3M | (16.8M) | (15.1M) | (14.4M) | |
| Capital Expenditures | 11.8M | 18.4M | 34.6M | 22.1M | 25.4M | 21.5M | |
| Net Income | (259.2M) | (289.8M) | (214.1M) | (705.8M) | (635.2M) | (603.5M) | |
| End Period Cash Flow | 278.5M | 303.7M | 166.6M | 341.8M | 307.7M | 244.4M | |
| Investments | (21.7M) | (57.9M) | (40.3M) | (130.4M) | (117.4M) | (111.5M) |
Tempus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tempus AI's current stock value. Our valuation model uses many indicators to compare Tempus AI value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tempus AI competition to find correlations between indicators driving Tempus AI's intrinsic value. More Info.Tempus AI Class is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Tempus AI's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Tempus AI by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Tempus AI Class Systematic Risk
Tempus AI's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tempus AI volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Tempus AI Class correlated with the market. If Beta is less than 0 Tempus AI generally moves in the opposite direction as compared to the market. If Tempus AI Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tempus AI Class is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tempus AI is generally in the same direction as the market. If Beta > 1 Tempus AI moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Tempus AI Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tempus AI's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Tempus AI growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Tempus AI January 8, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Tempus AI help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tempus AI Class. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tempus AI Class based on widely used predictive technical indicators. In general, we focus on analyzing Tempus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tempus AI's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 23.37 | |||
| Value At Risk | (4.95) | |||
| Potential Upside | 7.0 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tempus AI Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tempus AI. If investors know Tempus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tempus AI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.29) | Revenue Per Share | Quarterly Revenue Growth 0.847 | Return On Assets | Return On Equity |
The market value of Tempus AI Class is measured differently than its book value, which is the value of Tempus that is recorded on the company's balance sheet. Investors also form their own opinion of Tempus AI's value that differs from its market value or its book value, called intrinsic value, which is Tempus AI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tempus AI's market value can be influenced by many factors that don't directly affect Tempus AI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tempus AI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tempus AI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tempus AI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.